The cost-effectiveness of prostate cancer screening using the Stockholm3 test.

Andreas A KarlssonShuang HaoAlexandra JauhiainenK Miriam ElfströmLars EgevadTobias NordströmEmelie HeintzMark S Clements

Published in: PloS one (2021)

Prostate cancer screening using the S3M test for men with an initial PSA ≥ 2.0 ng/mL was cost-effective compared with screening using the PSA test alone.

Keyphrases

prostate cancer
radical prostatectomy
middle aged